Glucagon-Like Peptide-1 and Glucose-Dependent Insulin-Releasing Polypeptide Plasma Levels in Response to Nutrients
The DOI matches its Crossref record, with a small difference in title or year.
Abstract
The nutrient-dependent glucagon-like peptide-1 (7-36) amide (GLP-1) release was studied in comparison to the glucose-dependent insulin-releasing polypeptide (GIP) response in 10 healthy volunteers each undergoing various protocols. Plasma samples were saved up to 120 min after challenges by oral, intravenous or intraduodenal administration of nutrients. Basal plasma-GLP-1 concentrations ranged between 0.4 and 1.4 pM, maximal postprandial GLP-1 levels peaked between 10 and 12 pM. Intravenous glucose (25 g i.v.) did not change basal GLP-1 levels. Oral administration of glucose (50 g) induced a biphasic GLP-1 release peaking at 30-60 min and a biphasic GIP release peaking at 5 and 45 min. This increase paralleled the secretion of insulin. Oral galactose (100 g) and amino acids (25 g) also induced a rapid plasma GLP-1 response. After fat (67 g corn oil) a strong and long-lasting (> 120 min) increase of GLP-1 plasma levels occurred. When a mixed liquid meal was given (6 g soybean oil, 5 g casein, 13 g glucose) immunoreactive (IR)-GLP-1 rapidly increased and peaked after 5 min with declining levels after 30 min. In response to an intraduodenal infusion of a small glucose load (5.34 g within 120 min) a rapid, short-lasting GLP-1 response occurred whereas plasma GIP and insulin levels remained unaltered. Luminal perfusion of an isolated vascularly perfused rat ileum with a polydiet induced a rapid rise of portally released IR-GLP-1 which was followed by a sustained release. Glucose e…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among these hormones, the most studied are the incretin hormones like GLP-1 and GIP that are secreted mainly by the intestine in response to a meal [7] (Figure 1).”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [7]
Citations
Cites
Still being checked.
Cited by
Items 101–200 of 613
GLP-1 does not acutely affect insulin sensitivity in healthy man
Ørskov, L., Holst, J. J., Møller, J., Ørskov, C., Møller, N., Alberti, K. G. M. M., & Schmitz, O. (1996) · Diabetologia · doi:10.1007/bf02658511 · Cited by 123
Little, T. J., & Feinle‐Bisset, C. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.04.038 · Cited by 117
Bowen, J., Noakes, M., & Clifton, P. M. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803665 · Cited by 118
GLUT2 and the incretin receptors are involved in glucose-induced incretin secretion
Cani, P. D., Holst, J. J., Drucker, D. J., Delzenne, N. M., Thorens, B., Burcelin, R., & Knauf, C. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.06.003 · Cited by 106
Role of central glucagon-like peptide-1 in stress regulation
Ghosal, S., Myers, B., & Herman, J. P. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.04.003 · Cited by 107
Monteiro, M. P., & Batterham, R. L. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.053 · Cited by 105
Mannucci, E., Ognibene, A., Cremasco, F., Bardini, G., Mencucci, A., Pierazzuoli, E., Ciani, S., Fanelli, A., Messeri, G., & Rotella, C. M. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00367.x · Cited by 106
Release of glucagon-like peptide-1 (GLP-1) by carbohydrates in the perfused rat ileum
Ritzel, U., Fromme, A., Ottleben, M., Leonhardt, U., & Ramadori, G. P. (1997) · Acta Diabetologica · doi:10.1007/s005920050059 · Cited by 115
Aronis, K. N., Chamberland, J. P., & Mantzoros, C. S. (2013) · Metabolism · doi:10.1016/j.metabol.2013.04.010 · Cited by 104
“[18], while its concentrations can reach up to 2000 pmol/L after administration of pharmacologic doses of GLP-1 [19], and 10.”
BackgroundZarrinpar, A., & Loomba, R. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12084 · Cited by 103
GLP-1 based therapy for type 2 diabetes
Arulmozhi, D. K., & Portha, B. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.01.003 · Cited by 113
Gault, V. A., O'Harte, F. P. M., Harriott, P., & Flatt, P. R. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6364 · Cited by 108
Effects of oral fructose and glucose on plasma GLP-1 and appetite in normal subjects
Kong, M., Chapman, I. M., Goble, E., Wishart, J. M., Wittert, G., Morris, H. A., & Horowitz, M. (1999) · Peptides · doi:10.1016/s0196-9781(99)00006-6 · Cited by 115
Gut hormones and appetite control
Hameed, S., Dhillo, W., & Bloom, Sr. (2009) · Oral Diseases · doi:10.1111/j.1601-0825.2008.01492.x · Cited by 98
Is glucagon-like peptide 1 an incretin hormone?
Nauck, M. A. (1999) · Diabetologia · doi:10.1007/s001250051165 · Cited by 112
Steinert, R. E., & Beglinger, C. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.02.039 · Cited by 116
Outeiriño-Iglesias, V., Romaní-Pérez, M., González-Matías, L. C., Vigo, E., & Mallo, F. (2015) · Endocrinology · doi:10.1210/en.2014-1978 · Cited by 99
Integration of Satiety Signals by the Central Nervous System
Chambers, A. P., Sandoval, D. A., & Seeley, R. J. (2013) · Current Biology · doi:10.1016/j.cub.2013.03.020 · Cited by 90
Chisholm, C., & Greenberg, G. R. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00434.2001 · Cited by 96
Gaborit, B., Julla, J.-B., Besbes, S., Proust, M., Vincentelli, C., Alos, B., Ancel, P., Alzaid, F., Garcia, R., Mailly, P., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz069 · Cited by 95
Effect of GIP and GLP-1 antagonists on insulin release in the rat
Tseng, C.-C., Zhang, X.-Y., & Wolfe, M. M. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.6.e1049 · Cited by 95
Glucagon-like peptide 1 (GLP-1): a potent gut hormone with a possible therapeutic perspective
Nauck, M. A. (1998) · Acta Diabetologica · doi:10.1007/s005920050116 · Cited by 94
Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus
León, D. D. D., Crutchlow, M. F., Ham, J.-Y. N., & Stoffers, D. A. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.07.011 · Cited by 94
Cyclic AMP triggers glucagon-like peptide-1 secretion from the GLUTag enteroendocrine cell line
Simpson, A. K., Ward, P. S., Wong, K. Y., Collord, G. J., Habib, A. M., Reimann, F., & Gribble, F. M. (2007) · Diabetologia · doi:10.1007/s00125-007-0750-9 · Cited by 88
Proglucagon-Derived Peptides: Mechanisms of Action and Therapeutic Potential
Sinclair, E. M., & Drucker, D. J. (2005) · Physiology · doi:10.1152/physiol.00030.2005 · Cited by 87
Reappraising the role of the vagus nerve in GLP-1-mediated regulation of eating
Brierley, D. I., & de Lartigue, G. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15603 · Cited by 92
The gut endocrine system as a coordinator of postprandial nutrient homoeostasis
Gribble, F. M. (2012) · Proceedings of the Nutrition Society · doi:10.1017/s0029665112000705 · Cited by 89
Decreased Glucagon‐like Peptide 1 Release after Weight Loss in Overweight/Obese Subjects
Adam, T. C. M., Jocken, J., & Westerterp‐Plantenga, M. S. (2005) · Obesity Research · doi:10.1038/oby.2005.80 · Cited by 91
Suzuki, T., Oba, K., Igari, Y., Matsumura, N., Watanabe, K., Futami-Suda, S., Yasuoka, H., Ouchi, M., Suzuki, K., Kigawa, Y., et al. (2007) · Journal of Nippon Medical School · doi:10.1272/jnms.74.338 · Cited by 93
Lengsfeld, S., Burkard, T., Meienberg, A., Jeanloz, N., Vukajlovic, T., Bologna, K., Steinmetz, M., Bathelt, C., Sailer, C. O., Vogt, D. R., et al. (2023) · eClinicalMedicine · doi:10.1016/j.eclinm.2023.101865 · Cited by 81
Coming full circle in diabetes mellitus: from complications to initiation
Harcourt, B. E., Penfold, S. A., & Forbes, J. M. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.236 · Cited by 97
Role of TCF7L2 risk variant and dietary fibre intake on incident type 2 diabetes
Hindy, G., Sonestedt, E., Ericson, U., Jing, X.-J., Zhou, Y., Hansson, O., Renström, E., Wirfält, E., & Orho-Melander, M. (2012) · Diabetologia · doi:10.1007/s00125-012-2634-x · Cited by 89
Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1
Xiong, Y., Swaminath, G., Cao, Q., Li, Y., Guo, Q., Salomonis, H., Lu, J. Y.-L., Houze, J. B., Dransfield, P. J., Wang, Y., et al. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.009 · Cited by 96
Ayoub, M., Chela, H. K., Amin, N. A., Hunter, R., Anwar, J., Tahan, V., & Daglilar, E. S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14030944 · Cited by 94
Pabreja, K., Mohd, M. A., Koole, C., Wootten, D., & Furness, S. G. B. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12313 · Cited by 84
Changes in Gastrointestinal Hormones and Leptin After Roux‐en‐Y Gastric Bypass Surgery
Beckman, L. M., Beckman, T. R., Sibley, S. D., Thomas, W., Ikramuddin, S., Kellogg, T. A., Ghatei, M. A., Bloom, S. R., le Roux, C. W., & Earthman, C. P. (2011) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607110381403 · Cited by 86
Peripheral tissue–brain interactions in the regulation of food intake
López, M., Tovar, S. A., Vazquez, M. J., Williams, L. M., & Diéguez, C. (2007) · Proceedings of The Nutrition Society · doi:10.1017/s0029665107005368 · Cited by 98
Electrical activity‐triggered glucagon‐like peptide‐1 secretion from primary murine L‐cells
Rogers, G. J., Tolhurst, G., Ramzan, A., Habib, A. M., Parker, H. E., Gribble, F. M., & Reimann, F. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2010.198069 · Cited by 86
Relation between gastric emptying of glucose and plasma concentrations of glucagon-like peptide-1
Wishart, J. M., Horowitz, M., Morris, H. A., Jones, K. L., & Nauck, M. A. (1998) · Peptides · doi:10.1016/s0196-9781(98)00052-7 · Cited by 95
Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide
Candeias, E. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i6.807 · Cited by 83
Lewis, J. T., Dayanandan, B., Habener, J. F., & Kieffer, T. J. (2000) · Endocrinology · doi:10.1210/endo.141.10.7750 · Cited by 85
Dipeptidyl peptidase IV (DPP IV) and related molecules in type 2 diabetes
Flatt, P. R. (2008) · Frontiers in bioscience · doi:10.2741/2956 · Cited by 89
Šalković‐Petrišić, M., Barilar, J. O., Knezović, A., Hoyer, S., Mosetter, K., & Reutter, W. G. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.002 · Cited by 89
The relevance of the glycaemic index to our understanding of dietary carbohydrates
Frost, G., & Dornhorst, A. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00266.x · Cited by 82
Mechanism of glucose-lowering by metformin in type 2 diabetes: Role of bile acids
Sansome, D. J., Xie, C., Veedfald, S., Horowitz, M., Rayner, C. K., & Wu, T. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13869 · Cited by 84
Gut Peptide Signaling in the Controls of Food Intake
Moran, T. H. (2006) · Obesity · doi:10.1038/oby.2006.318 · Cited by 81
Metabolic hormones are integral regulators of female reproductive health and function
Athar, F., Karmani, M., & Templeman, N. M. (2024) · Bioscience Reports · doi:10.1042/bsr20231916 · Cited by 91
Feinle, C., Chapman, I. M., Wishart, J. M., & Horowitz, M. (2002) · Peptides · doi:10.1016/s0196-9781(02)00087-6 · Cited by 89
Pilichiewicz, A., O’Donovan, D., Feinle, C., Lei, Y., Wishart, J. M., Bryant, L., Meyer, J. H., Horowitz, M., & Jones, K. L. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030199 · Cited by 81
Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity
Anandhakrishnan, A., & Korbonits, M. (2016) · World Journal of Diabetes · doi:10.4239/wjd.v7.i20.572 · Cited by 82
Damholt, A. B., Kofod, H., & Buchan, A. M. J. (1999) · Cell and Tissue Research · doi:10.1007/s004419900093 · Cited by 89
The Sensory Mechanisms of Nutrient-Induced GLP-1 Secretion
Hjørne, A. P., Modvig, I. M., & Holst, J. J. (2022) · Metabolites · doi:10.3390/metabo12050420 · Cited by 71
Minor, R. K., Chang, J. W., & de Cabo, R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.044 · Cited by 77
Recent advances in understanding GLP-1R (glucagon-like peptide-1 receptor) function
Koole, C., Pabreja, K., Savage, E. E., Wootten, D., Furness, S. G. B., Miller, L. J., Christopoulos, A., & Sexton, P. M. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120236 · Cited by 75
Damholt, A. B. (1998) · Endocrinology · doi:10.1210/en.139.4.2085 · Cited by 72
Effect of fat on glycaemic responses in normal subjects: a dose-response study
Owen, B., & Wolever, T. M. S. (2003) · Nutrition Research · doi:10.1016/s0271-5317(03)00149-0 · Cited by 76
Glucagon-like peptide-1 and glucagon-like peptide-2
Baggio, L. L., & Drucker, D. J. (2004) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.08.001 · Cited by 82
TRPM5 is critical for linoleic acid-induced CCK secretion from the enteroendocrine cell line, STC-1
Shah, B. P., Pin, L., Yu, T., Hansen, D. R., & Gilbertson, T. A. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00209.2011 · Cited by 75
Stimson, R. H., Mohd-Shukri, N. A., Bolton, J. L., Andrew, R., Reynolds, R. M., & Walker, B. R. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2307 · Cited by 74
Damcı, T., Yalın, S., Balcı, H., Oşar, Z., Korugan, Ü., Özyazar, M., & ILKOVA, H. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1077 · Cited by 78
The effects of duodenal peptides on glucagon-like peptide-1 secretion from the ileum
Hansen, L., & Holst, J. J. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00157-x · Cited by 81
Kořínková, L., Pražienková, V., Černá, L., Karnošová, A., Železná, B., Kuneš, J., & Maletínská, L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.597583 · Cited by 81
The Role of cAMP in Beta Cell Stimulus–Secretion and Intercellular Coupling
Stožer, A., Leitgeb, E. P., Pohorec, V., Dolenšek, J., Bombek, L. K., Gosak, M., & Klemen, M. S. (2021) · Cells · doi:10.3390/cells10071658 · Cited by 75
Signaling Mechanisms Underlying the Release of Glucagon-Like Peptide 1
Reimann, F., Ward, P. S., & Gribble, F. M. (2006) · Diabetes · doi:10.2337/db06-s010 · Cited by 68
Intestinal GLP-1 and satiation: from man to rodents and back
Steinert, R. E., Beglinger, C., & Langhans, W. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.172 · Cited by 78
Incretin Mimetics as Emerging Treatments for Type 2 Diabetes
Joy, S. V., Rodgers, P. T., & Scates, A. C. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e245 · Cited by 71
The incretins: a link between nutrients and well-being
Burcelin, R. (2005) · British Journal of Nutrition · doi:10.1079/bjn20041340 · Cited by 70
Farokhnia, M., Tazare, J., Pince, C. L., Bruns, N., Gray, J. C., Re, V. L., Fiellin, D. A., Kranzler, H. R., Koob, G. F., Justice, A. C., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci188314 · Cited by 72
Sweetness and bitterness taste of meals per se does not mediate gastric emptying in humans
Little, T. J., Gupta, N., Case, R. M., Thompson, D. G., & McLaughlin, J. T. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00090.2009 · Cited by 69
Intravenous CCK-8, but not GLP-1, suppresses ghrelin and stimulates PYY release in healthy men
Brennan, I. M., Otto, B., Feltrin, K. L., Meyer, J. H., Horowitz, M., & Feinle‐Bisset, C. (2006) · Peptides · doi:10.1016/j.peptides.2006.10.014 · Cited by 74
Brennan, I. M., Feltrin, K. L., Horowitz, M., Smout, A. J. P. M., Meyer, J. H., Wishart, J., & Feinle-Bisset, C. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00732.2004 · Cited by 68
CHILTON, R. J., Wyatt, J., Nandish, S., OLIVEROS, R. A., & Lujan, M. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.11.004 · Cited by 72
Protein Digestion-Derived Peptides and the Peripheral Regulation of Food Intake
Caron, J., Domenger, D., Dhulster, P., Ravallec, R., & Cudennec, B. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00085 · Cited by 61
Modvig, I. M., Kuhre, R. E., & Holst, J. J. (2019) · Physiological Reports · doi:10.14814/phy2.14056 · Cited by 64
Wettergren, A., Wøjdemann, M., & Holst, J. J. (1998) · Peptides · doi:10.1016/s0196-9781(98)00020-5 · Cited by 67
Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH
Svegliati-Baroni, G., Patrício, B., Lioci, G., Macedo, M. P., & Gastaldelli, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165820 · Cited by 66
“The secretion of the incretin hormones GLP-1 and GIP occurs in the intestine in response to a meal [7] (Figure 1).”
BackgroundO'Harte, F. P., Mooney, M. H., & Flatt, P. R. (1999) · Diabetes · doi:10.2337/diabetes.48.4.758 · Cited by 68
GLP-1 receptor agonist ameliorates experimental lung fibrosis
Fandiño, J., Toba, L., González-Matías, L. C., Diz-Chaves, Y., & Mallo, F. (2020) · Scientific Reports · doi:10.1038/s41598-020-74912-1 · Cited by 59
Hellström, P. M. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835d9ff8 · Cited by 74
Obesity treatment: novel peripheral targets
Field, B. C. T., Chaudhri, O. B., & Bloom, S. R. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03522.x · Cited by 64
Ding, K.-H., Zhong, Q., Xu, J., & Isales, C. M. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00507.2003 · Cited by 63
Hasek, L. Y., Phillips, R. J., Zhang, G., Kinzig, K. P., Kim, C. Y., Powley, T. L., & Hamaker, B. R. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700117 · Cited by 60
Modvig, I. M., Kuhre, R. E., Jepsen, S. L., Xu, S. F. S., Engelstoft, M. S., Egerod, K. L., Schwartz, T. W., Ørskov, C., Rosenkilde, M. M., & Holst, J. J. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00026.2021 · Cited by 58
Thomas, M. C., Coughlan, M. T., & Cooper, M. E. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.01.004 · Cited by 56
Schirra, J., Leicht, P., Hildebrand, P., Beglinger, C., Arnold, R., Goke, B., & Katschinski, M. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560177 · Cited by 65
Self-citationHuber, H., Schieren, A., Holst, J. J., & Simon, M.-C. (2024) · The American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2024.01.007 · Cited by 62
“…been described to be strong GLP-1 secretagogues after they have been orally ingested or directly administered into the intestine [32,124 – 126]; with carbohydrate and proteins eliciting earlier peaks in GLP-1 secretion (30 – 60 min postprandially) than lipids ( > 120 min postprandially) [32,127].”
BackgroundSteinert, R. E., Feinle‐Bisset, C., Geary, N., & Beglinger, C. (2013) · Journal of Animal Science · doi:10.2527/jas.2012-6022 · Cited by 67
A synthetic glucagon-like peptide-1 analog with improved plasma stability
Ritzel, U., Leonhardt, U., Ottleben, M., Ruhmann, A., Eckart, K., Spiess, J., & Ramadori, G. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1590093 · Cited by 61
Li, J., An, R., Zhang, Y., Li, X., & Wang, S. (2012) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.037440 · Cited by 66
Punjabi, M., Arnold, M., Rüttimann, E., Graber, M., Geary, N., Pacheco-López, G., & Langhans, W. (2014) · Endocrinology · doi:10.1210/en.2013-1447 · Cited by 59
Flock, G. B., Cao, X., Maziarz, M., & Drucker, D. J. (2012) · Diabetes · doi:10.2337/db12-0601 · Cited by 59
Dietary Effects on Incretin Hormone Secretion
Wu, T., Rayner, C. K., Jones, K. L., & Horowitz, M. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00003-5 · Cited by 62
Mechanisms and effects of “fat taste” in humans
Tucker, R. M., Mattes, R. D., & Running, C. A. (2014) · BioFactors · doi:10.1002/biof.1162 · Cited by 61
Power-Grant, O., Bruen, C. M., Brennan, L., Giblin, L., Jakeman, P. M., & Fitzgerald, R. J. (2015) · Food & Function · doi:10.1039/c4fo00983e · Cited by 58
Nora, M. C., Morais, T., Almeida, R., Guimarães, M., & Monteiro, M. P. (2017) · Medicine · doi:10.1097/md.0000000000008859 · Cited by 67
Intestinal hormones and growth factors: Effects on the small intestine
Drozdowski, L. A., & Thomson, A. B. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.385 · Cited by 63
Marrano, N., Biondi, G., Borrelli, A., Cignarelli, A., Perrini, S., Laviola, L., Giorgino, F., & Natalicchio, A. (2021) · Biomolecules · doi:10.3390/biom11020286 · Cited by 56
“with an early (within 10–15 min) phase that is followed by a longer (30–60 min) second phase [13].”
BackgroundEffect of macronutrient composition on short-term food intake and weight loss
Bellissimo, N., & Akhavan, T. (2015) · Advances in Nutrition · doi:10.3945/an.114.006957 · Cited by 56
The TRPA1 Agonist, Methyl Syringate Suppresses Food Intake and Gastric Emptying
Kim, M. J., Son, H. J., Song, S. H., Jung, M., Kim, Y., & Rhyu, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071603 · Cited by 58
Lu, W. J., Yang, Q., Sun, W., Woods, S. C., D'Alessio, D., & Tso, P. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00146.2007 · Cited by 55
Metadata
- Authors
- Herrmann, C., Göke, R., Richter, G., Fehmann, H.-C., Arnold, R., & Göke, B.
- Affiliations
- Philipps University of Marburg (DE)
- Venue
- Digestion
- Publisher
- S. Karger AG
- Published
- 2009-02-05
- Volume
- 56
- Issue
- 2
- Pages
- 117-126
- ISSN
- 0012-2823 (ISSN-L)
- 1421-9867
- OpenAlex
- W2064492226
- Cited by
- 597
- References
- 0
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 17 · 2023: 23 · 2022: 19 · 2021: 24 · 2020: 18 · 2019: 23 · 2018: 22 · 2017: 22 · 2016: 13 · 2015: 20 · 2014: 26 · 2013: 39 · 2012: 32
- FWCI
- 27.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- Digestion (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide, GLP-1 secretion, GIP secretion, postprandial hormone release, nutrient stimulation, oral glucose, intraduodenal glucose infusion, amino acids, galactose, insulin secretion
- MeSH terms
- Insulin Secretion, Adult, Amino Acids, Animals, Diet, Glucagon-Like Peptides, Fats, Food, Galactose, Glucagon, Glucose, Humans, Insulin, Male, Peptide Fragments, Peptides, Protein Precursors, Rats, Wistar, Rats, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.